Galway Start-up Tackles Major Wound Care Challenge
Spiddal (An Spidéal), a seaside town on Ireland’s west coast, takes its name from Ospidéal, (Irish for “hospital”), a nod to a medieval medical facility once located there. Fittingly, it’s now home to FeelTect, a connected health start-up founded in 2019 to revolutionise wound care through innovative technology.
At the heart of FeelTect’s mission is a commitment to patients, driven by research and the development of connected health solutions with the potential to improve care worldwide.
Innovating with Tight Alright
FeelTect emerged from a clinical need identified in compression therapy monitoring. In response, the team developed Tight Alright – “the world’s first connected health technology for measuring and monitoring compression therapy.” according to Darren Burke, CTO and Co-Founder.
Darren explains, “The clinical need that the company is founded on came from the BioInnovate program in 2016. Following that, we spent two years in the university developing that need and spun out the company in 2019.”
Tight Alright offers real-time monitoring, enabling clinicians to manage compression therapy more accurately while supporting remote care and patient self-management for chronic wounds.
This breakthrough addresses a major challenge in wound care by improving accuracy, enhancing clinical decisions, and boosting patient outcomes. Early clinical studies are already showing promising results. According to Andrew Cameron, CEO & Co-Founder “Our recent clinical studies have shown a three times acceleration in healing rates for venous leg ulcer patients”
Powered by Support and Investment
As a medical device company, FeelTect must navigate a complex path to market, including regulatory, clinical, technical, and commercial challenges that demand significant resources. Early support from the Western Investment Fund was vital in helping the company through these formative stages.
The Western Investment Fund has been critical for our early stages of development, As a medical device company, we have a long, hard road that includes regulatory, clinical, commercial, and technical elements - and that takes a lot of resources. That funding has been extremely important and valuable for us, positioning us for growth and success.
Andrew Cameron, CEO & Co-Founder
Global Milestones Achieved
In recent years, FeelTect has secured key certifications crucial for global market access. Andrew highlights the progress: “Over the years, FeelTect has achieved a number of significant milestones. We have FDA registration, CE mark, and recently we had TGA registration in Australia.”
Looking Ahead – Launching Commercially in October 2025
FeelTect is set to launch Tight Alright commercially in 2025, marking a significant milestone for both the company and patients worldwide. As it moves into commercialisation, the company remains committed to its mission to transform the model of care and improve the lives of patients suffering from chronic wounds.
Darren explains: “Since the company started, we’ve been testing and verifying the product in clinical studies and we’re now ready to launch the product commercially this year, which is super exciting for us.”
Reflecting on the milestone’s significance, Andrew adds, “We’re really excited about that because we’ll transform the model of care and transform the lives of millions of patients.”
Local Roots, Global Reach
While FeelTect pursues global ambitions, the company remains firmly anchored in the west of Ireland. Its new headquarters in Spiddal, County Galway, reflects both its Irish roots and its drive to become a leading player in the global MedTech industry.
“We love working in Spiddal” Darren says, “It has everything we need to support us in our journey to becoming a global MedTech company.”
Backed by an award-winning team of medical and engineering experts, FeelTect combines innovation with a growing team, positioning itself as a rising force in connected health.